News

As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.

cardiologists evaluating the human heart to provide a treatment strategy

The new patch is implanted through a tiny incision and held in place with a biocompatible adhesive. It then helps the heart recover over time, replacing dead tissue that would typically never be able to regenerate. 

Video Robert Lookstein on mechanical thrombectomy beating anticoagulation alone in pulmonary embolism in the late-breaking STORM-PE trial at TCT 2025.

Highly anticipated trial data comparing mechanical thrombectomy to anticoagulation alone for intermediate- and high-risk pulmonary embolism showed that the more aggressive strategy improved outcomes.

heart data research doctor cardiologist AI

In fact, researchers wrote, MAC appears to influence a patient's odds of developing HFpEF even more than their BMI.

The shunt device being reviewed showed a 52% reduction in hospitalizations and favorable trends in mortality in patients with heart failure with reduced ejection fraction. 

centennial

Pulmonary embolism (PE) remains one of the leading causes of cardiovascular death in the United States. TriStar Health, part of HCA Healthcare, has made PE a priority by bringing together a multidisciplinary team and adopting AI-enabled workflows to support timely diagnosis and treatment. This approach is designed to drive consistent, high-quality care – whether patients are seen at a large hospital or a community ER.

Shockwave Medical Javelin Peripheral IVL Catheter

The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.

startup business healthcare medtech heart

Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

Thumbnail

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare HVAD system. This is a Class I recall, which means using the device can lead to serious injury or death. The new recall includes more than 1,600 devices distributed from October 2006 to June 2021.

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.